(Q46077552)

19 December 2017

title

Disruption in prepulse inhibition after alpha-1 adrenoceptor stimulation in rats (English)

1 reference

19 December 2017

author name string

Carasso BS

series ordinal

1

1 reference

19 December 2017

Bakshi VP

series ordinal

2

1 reference

19 December 2017

Geyer MA

series ordinal

3

1 reference

19 December 2017

publication date

1 January 1998

1 reference

19 December 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

Neuropharmacology

1 reference

19 December 2017

volume

37

1 reference

19 December 2017

page(s)

401-404

1 reference

19 December 2017

issue

3

1 reference

19 December 2017

Spinal modulation of the acoustic startle response: the role of norepinephrine, serotonin and dopamine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900051-3

Sensorimotor gating and schizophrenia. Human and animal model studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900051-3

Potentiation of prepulse inhibition of the startle reflex in rats: pharmacological evaluation of the procedure as a model for detecting antipsychotic activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900051-3

Differences in imidazoline and phenylethylamine alpha-adrenergic agonists: comparison of binding affinity and phosphoinositide response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900051-3

Seroquel: biochemical profile of a potential atypical antipsychotic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900051-3

Nasal Spray ‘Addiction’ and Psychosis: A Case Report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900051-3

Disruption of sensory gating by the alpha 2 selective noradrenergic antagonist yohimbine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900051-3

Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900051-3

10.1016/S0028-3908(98)00051-3

7 January 2021

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

9681939

1 reference

19 December 2017